Company intelligence / Profile preview
ReGenesys
Heverlee, Flanders, Belgiumregenesys.net ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ReGenesys is a clinical-stage biotechnology company developing cell therapies based on multipotent adult progenitor cells to extend and enhance human life. It has conducted preclinical research in animals and is engaged in clinical development for human indications, leveraging its parent company Athersys' MAPC platform. Recent activities include licensing out animal health assets but maintaining focus on human therapeutic development.
- Therapeutic areas
- Rheumatology
- Modalities
- Cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on ReGenesys.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReGenesys.